BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

King Pharmaceuticals®, Inc. 

501 Fifth Street

Bristol  Tennessee  37620  U.S.A.
Phone: 423-989-8000 Fax: 423-274-8677


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Pfizer Inc. (PFE) to Shed 130 Jobs and Close Former King Pharmaceuticals®, Inc. Plant 8/11/2011 7:30:19 AM    More...
DURECT Corporation (DRRX) Announces King Pharmaceuticals®, Inc.'s ELADUR(R) (TRANSDUR(R)-Bupivacaine) Phase II Study Results in Chronic Low Back Pain 4/12/2011 8:52:19 AM    More...
Pfizer Inc. (PFE) Recalls Pain Drug Acquired in King Pharmaceuticals®, Inc. Deal 3/17/2011 8:41:42 AM    More...
King Pharmaceuticals®, Inc. Announces Final Results of Its Offer to Purchase Convertible Notes 3/1/2011 1:52:35 PM    More...
Pfizer Inc. (PFE) Completes Acquisition Of King Pharmaceuticals®, Inc. 3/1/2011 10:58:46 AM    More...
King Pharmaceuticals®, Inc. Announces Intent to Voluntarily Delist From the New York Stock Exchange 2/8/2011 8:40:34 AM    More...
King Pharmaceuticals®, Inc. Announces Offer to Purchase Any and All of Its Outstanding 1 1/4% Convertible Senior Notes Due 2026 Through a Tender Offer 2/1/2011 8:31:44 AM    More...
Pain Therapeutics (PTIE) Receives $5,000,000 Payment from King Pharmaceuticals®, Inc. 1/28/2011 7:18:35 AM    More...
DURECT Corporation (DRRX), King Pharmaceuticals®, Inc.'s REMOXY(R) New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 1/27/2011 7:40:56 AM    More...
Pfizer Inc. (PFE) Extends Tender Offer to Acquire King Pharmaceuticals®, Inc. to January 28, 2011 1/21/2011 6:42:25 AM    More...
12345678910...